Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease

Abstract excerpt

Inherited retinal degenerations cause progressive loss of photoreceptor neurons with eventual blindness. Corrective or neuroprotective gene therapies under development could be delivered at a predegeneration stage to prevent the onset of disease, as well as at intermediate-degeneration stages to slow the rate of progression. Most preclinical gene therapy successes to date have been as predegeneration...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ocular Disorders and Treatments
• Share to Retinal Development and Disorders
• Share to Retinal Diseases and Treatments